| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
1 company
Rothschild Jonathan E serves as a Director at ICCC. Across recent SEC filings that breaks down to 36 buys and 0 sells. Those positions are worth an estimated $3.6M at current prices.
The biggest single holding is ICCC (~$3.6M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 42,622 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2016 | ICCC Immucell Corp /de/ | Director, 10% Owner | Buy | 9,522 | $5.25 | $49,990.50 | +1.9% | |
| Nov 11, 2015 | ICCC Immucell Corp /de/ | Director, 10% Owner | Buy | 24,000 | $0.00 | - | +5.0% | |
| Sep 3, 2015 | ICCC Immucell Corp /de/ | Director, 10% Owner | Buy | 3,000 | $6.63 | $19,881.00 | +0.6% | |
| Aug 31, 2015 | ICCC Immucell Corp /de/ | Director, 10% Owner | Buy | 6,100 | $7.37 | $44,967.50 | +1.2% |